SCHEMBL3375836

SCHEMBL3375836

CCSCCNC(=O)c1c(OS(C)(=O)=O)cccc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
PKM P14618 2/20 0.42
HCRTR1 O43613 2/20 0.38
POLB P06746 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
CCR2 P41597 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5716640 0.93 HCRTR1 (0.40) ALDH1A1KDM4EPKMHCRTR1TAAR1
SCHEMBL3375839 0.91 ALDH1A1 (0.45) ALDH1A1KDM4EPKMHCRTR1APOBEC3A
SCHEMBL3376465 0.91 ALDH1A1 (0.40) ALDH1A1KDM4EPKMHCRTR1POLB
SCHEMBL3377448 0.88 MEN1 (0.41) ALDH1A1KDM4EPKMHCRTR1POLB
SCHEMBL3376179 0.88 DRD2 (0.39) ALDH1A1KDM4EPKMHCRTR1POLB
SCHEMBL3377281 0.87 CA12 (0.43) ALDH1A1KDM4EHCRTR1TAAR1MEN1
SCHEMBL3376163 0.85 TSHR (0.50) ALDH1A1KDM4EHCRTR1MEN1KMT2A
SCHEMBL3376469 0.82 ALDH1A1 (0.42) ALDH1A1KDM4EPKMHCRTR1APOBEC3A
SCHEMBL3377879 0.81 MEN1 (0.39) ALDH1A1KDM4EPKMHCRTR1POLB
SCHEMBL2889720 0.80 MEN1 (0.37) ALDH1A1KDM4EMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 ALDH1A1 1071/4885KDM4E 973/4885PKM 1543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.